ClinicalTrials.gg
RecruitingNCT06051071Updated Sep 22, 2023

Home-based Stimulation to Promote Resilience

An interventional study of Transcranial Direct Current Stimulation (tDCS) in Stress, sponsored by Institut Guttmann. Recruiting at 1 site in Spain. Open to participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-22.

Sponsored by Institut Guttmann · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
40 Years to 70 Years
Sex
All
01

Study summary

Background:

Non-invasive brain stimulation showed to be effective in reduce stress related cognitive and mental-health consequences. Thanks to technological advances these devices are now very easy to use and suitable to hoe-based self-administration.

Objective:

Conduct a home-based and tele-supervised non-invasive brain stimulation intervention to modulate the expression of resilience brain networks.

Methods:

Transcranial direct current stimulation will be used duringa tele-supervised home-based stimulation intervention to promote the expression of brain resilience networks.

Expected results:

The present project should provide critical new knowledge and evidences of the feasibility and impact of modulating brain resilience networks in terms of its effects on mental health of participants, including the possibility to implement future self-administered, home-based interventions.

Read the detailed description

Resilience, the concept that describes the ability of certain individuals to resist, among others, the impact of stress, is a broad term.

In clinical psychology and mental health, the concept of resilience has historically been linked to the study of individual differences (e.g. self-esteem, sense of control, perception of social support, etc.) that determine the ability to cope with the impact of life traumas and maintain good psychological and physical functioning, avoiding mental illness.

Neuroimaging research has identified brain regions that show patterns of specific activity and connectivity during exposure to stressful or violent stimuli and may be correlated with scores on psychosocial resilience scales or predict coping capabilities.

In the same vein, our group has recently observed how certain connectivity patterns between frontal and parietal areas related to the default neural network (DMN) and pedimental-parietal network (FPN), are predictive of better stress resilience, which decreases the negative impact on mental health.

Together, these findings suggest the possible existence of brain circuits composed of nodes within medial dorsolateral and prefrontal brain areas, and their connections to parietal areas, specifically related to resilience capacity.

In this context non-invasive transcranial stimulation, a safe and effective procedure, provides us with a technique to modulate brain activity in these areas and potentially promote resilience.

Among the various techniques, direct current transcranial stimulation (tDCS) is one of the most studied and promising approaches.

In tDCS, surface electrodes (anode and cathode) inject low-intensity direct current through the skull to modulate brain activity and cortical excitability, with regulatory effects affecting not only areas brains stimulated, but also connected brain networks, and thus with the potential to "optimize" the balance between integration and segregation of associated functions.

Crucially, advances in technology have made tDCS devices more portable and user-friendly, with the possibility of being configured at a distance, and potentially allowing their home administration, with remote supervision, facilitating adherence to intervention protocols.

Goal The aim of this study is to assess the feasibility and effects of a direct intervention to promote resilience to stress

Materials and Method Study Design The researchers will implement an open trial with healthy adults performing a pre-stimulation assessment, a remotely supervised home intervention with tDCS, and a post-treatment assessment.

During the previous assessment, participants will receive training on the use of the stimulation device, as well as information material, and over the course of the intervention, and for the duration of the intervention researchers will remotely monitor the stimulation.

Participants This study will involve 40 healthy adults aged 40 to 65. The sample size has been calculated taking into account the grandor effect of previous studies investigating the modulating effect of non-invasive brain stimulation on functional and behavioral aspects related to resilience, defined as the ability to resist external and stressful factors.

The size of the required sample, considering alpha=0.05 and statistical power (1-beta) =0.80, has been estimated at between 30 and 38 individuals depending on the statistical test. Considering a possible abandonment of around 10%, the final sample will consist of 40 individuals.

Pre-Post Assessment Prior to the intervention, participants will be administered with questionnaires and a paradigm of stress induction.

Once the intervention is complete, the same tests will be repeated.

Stress Induction Paradigm In this task, developed by Limbachia and collaborators there are two circles that move at times by approaching and sometimes moving away from each other. When the circles are touched, the participants receive a soft electrical stressor stimulus. Circular motion has a high degree of unpredictability.

The stressful electric stimulus will be delivered by 500 ms through electrodes, to the fourth and fifth fingers of the left hand. To gauge the intensity of the shock, each participant will be asked to choose their own level of stimulation before the stress task, so that the stimulus is "unpleasant but not painful".

During the task, changes in skin conduction, heart rate, pupil diameter and changes in connectivity and network oscillation reflected by the signal electroencephalography will be recorded.

Feasibility Indicators To confirm the feasibility of such interventions, the investigators will evaluate adherence to intervention.

Stimulation training the researchers will undertake a first training session in person, followed by a training and remote monitoring program. These training sessions will aim to instruct and ensure the correct administration of stimulation.

Stimulation sessions oversight

The researchers will carry out remote monitoring throughout the duration of the intervention:

Investigators will monitor the first 2/3 stimulation sessions, second needs, and until participants need it. From the second week on, researchers will follow the intervention weekly through at least one video call per week.

TDCS stimulation protocol:

The stimulation session will last 20 minutes, following a protocol widely used in various studies.

Stimulation will be performed in the left dorsal lateral prefrontal cortex (L-DLPFC).

The current will be supplied steadily for 30 minutes and all the stimulation parameters to be used adhere to the general guidelines of the safety criteria of transcranial electric stimulation and, for safety reasons, the maximum supplied current will be 2 ma.

The stimulation will be delivered using the Sooma tDCSTM medical device used by health professionals worldwide. This device has acquired CE, Health Canada, MDA, HSA, TGA and COFEPRIS approvals. Sooma tDCSTM devices are manufactured in Finland under ISO 13485 standard.

02

Conditions studied

  • Stress
03

In context

Lead sponsor

Institut Guttmann is the lead sponsor of 19 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No psychiatric conditions or neurological disorders
  • Do not present any for their safety in relation to the TDCS protocol (crew metal implants, pacemakers, medical infusion bomb, epilepsy history, brain surgeries, etc.)

Exclusion criteria

Exclusion Criteria:

  • alcohol or drug abuse
  • pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Treatment

    tDCS stimulation arm

    Device: Transcranial Direct Current Stimulation (tDCS)

Interventions

  • DeviceTranscranial Direct Current Stimulation (tDCS)

    In tDCS, surface electrodes (anode and cathode) inject low-intensity direct current through the skull to modulate brain activity and cortical excitability

06

What researchers measure

Primary outcomes

  1. Changes in the Connor Davidson resilience scale

    A resilience scale scoring from 0 to 40, where higher score represent better resilience

    Time frame: immediately after the intervention

  2. Changes in the State-Trait Anxiety Inventory

    Anxiety scale scoring from 0 to 80 where higher scores indicates greater anxiety

    Time frame: immediately after the intervention

  3. Changes in the Holmes stress inventory

    stress scale scoring from 0 to 430 points, where higher scores indicates greater stress

    Time frame: immediately after the intervention

  4. Adherence

    number of sessions completed

    Time frame: immediately after the intervention

Secondary outcomes

  1. Heart rate variability changes

    Heart rate changes during the task

    Time frame: immediately after the intervention

  2. Pupill dilatation changes

    Pupil diameter changes during the task

    Time frame: immediately after the intervention

  3. Skin electrical activity changes

    Skin electrical activity changes during the task

    Time frame: immediately after the intervention

  4. EEG signal changes

    EEG signal changes during the task

    Time frame: immediately after the intervention

07

Study locations

1 of 1 sites recruiting
  • Guttmann Barcelona
    Barcelona, 08027, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2023 (actual). Primary completion is estimated for Nov 2023, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2023
First posted
Sep 22, 2023
StartActual
Sep 1, 2023
Primary completionEst.
Nov 15, 2023
CompletionEst.
Dec 31, 2023
Last update
Sep 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06051071
Lead sponsor
Institut Guttmann
Responsible party
Javier Solana Sanchez (Principal Investigator, Institut Guttmann) — Principal investigator
First posted
Sep 22, 2023
Start date
Sep 1, 2023
Primary completion
Nov 15, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Sep 22, 2023

Study contacts

Javier Solana-Sanchéz, PhD
Contact
jsolana@guttmann.com
+34 934 977 700
Gabriele Cattaneo, PhD
Contact
gcattaneo@guttmann.com
T. +34 934 977 700

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion